Shaping the interaction landscape of bioactive molecules
暂无分享,去创建一个
[1] Lazaros Mavridis,et al. Comprehensive Comparison of Ligand-Based Virtual Screening Tools Against the DUD Data set Reveals Limitations of Current 3D Methods , 2010, J. Chem. Inf. Model..
[2] Raman Sharma,et al. ElectroShape: fast molecular similarity calculations incorporating shape, chirality and electrostatics , 2010, J. Comput. Aided Mol. Des..
[3] Yanli Wang,et al. PubChem: Integrated Platform of Small Molecules and Biological Activities , 2008 .
[4] Jung-Hsin Lin,et al. idTarget: a web server for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approach , 2012, Nucleic Acids Res..
[5] Michael Schroeder,et al. Old friends in new guise: repositioning of known drugs with structural bioinformatics , 2011, Briefings Bioinform..
[6] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[7] Xiaomin Luo,et al. TarFisDock: a web server for identifying drug targets with docking approach , 2006, Nucleic Acids Res..
[8] W. Graham Richards,et al. Improving the accuracy of ultrafast ligand-based screening: incorporating lipophilicity into ElectroShape as an extra dimension , 2011, J. Comput. Aided Mol. Des..
[9] Lirong Wang,et al. TargetHunter: An In Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database , 2013, The AAPS Journal.
[10] Xiaoyan Zhu,et al. Building Disease-Specific Drug-Protein Connectivity Maps from Molecular Interaction Networks and PubMed Abstracts , 2009, PLoS Comput. Biol..
[11] Herbert Waldmann,et al. Target identification for small bioactive molecules: finding the needle in the haystack. , 2013, Angewandte Chemie.
[12] Lazaros Mavridis,et al. Detecting Drug Promiscuity Using Gaussian Ensemble Screening , 2012, J. Chem. Inf. Model..
[13] Stefan Wetzel,et al. The Scaffold Tree - Visualization of the Scaffold Universe by Hierarchical Scaffold Classification , 2007, J. Chem. Inf. Model..
[14] Paul W Finn,et al. Ultrafast shape recognition: evaluating a new ligand-based virtual screening technology. , 2009, Journal of molecular graphics & modelling.
[15] Ryan G. Coleman,et al. ZINC: A Free Tool to Discover Chemistry for Biology , 2012, J. Chem. Inf. Model..
[16] Xiaofeng Liu,et al. ChemMapper: a versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method , 2013, Bioinform..
[17] Ajay N. Jain,et al. Chemical structural novelty: on-targets and off-targets. , 2011, Journal of medicinal chemistry.
[18] A. Vulpetti,et al. The experimental uncertainty of heterogeneous public K(i) data. , 2012, Journal of medicinal chemistry.
[19] P. Bork,et al. Systematic identification of proteins that elicit drug side effects , 2013, Molecular systems biology.
[20] Z. Deng,et al. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors. , 2006, Journal of medicinal chemistry.
[21] Corey Nislow,et al. A survey of yeast genomic assays for drug and target discovery. , 2010, Pharmacology & therapeutics.
[22] Knut Baumann,et al. Impact of Benchmark Data Set Topology on the Validation of Virtual Screening Methods: Exploration and Quantification by Spatial Statistics , 2008, J. Chem. Inf. Model..
[23] T. Ashburn,et al. Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.
[24] Ajay N. Jain,et al. Effects of inductive bias on computational evaluations of ligand-based modeling and on drug discovery , 2008, J. Comput. Aided Mol. Des..
[25] Woody Sherman,et al. Rapid Shape-Based Ligand Alignment and Virtual Screening Method Based on Atom/Feature-Pair Similarities and Volume Overlap Scoring , 2011, J. Chem. Inf. Model..
[26] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[27] Tudor I. Oprea,et al. Scaffold Topologies. 1. Exhaustive Enumeration up to Eight Rings , 2008, J. Chem. Inf. Model..
[28] R. Tagliaferri,et al. Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.
[29] David S. Wishart,et al. DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..
[30] Natalia Novac,et al. Challenges and opportunities of drug repositioning. , 2013, Trends in pharmacological sciences.
[31] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[32] Stefan Günther,et al. SuperPred: drug classification and target prediction , 2008, Nucleic Acids Res..
[33] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[34] W. Graham Richards,et al. Ultrafast shape recognition to search compound databases for similar molecular shapes , 2007, J. Comput. Chem..
[35] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.
[36] M. Jackson,et al. The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator , 2009, Science.
[37] Katarzyna H. Kaminska,et al. Characterization of drug-induced transcriptional modules: towards drug repositioning and functional understanding , 2013, Molecular systems biology.
[38] Rainer Schrader,et al. Small Molecule Subgraph Detector (SMSD) toolkit , 2009, J. Cheminformatics.
[39] Aurélien Grosdidier,et al. Docking, virtual high throughput screening and in silico fragment-based drug design , 2009, Journal of cellular and molecular medicine.
[40] Matthias Wirth,et al. Bioactive Molecules: Perfectly Shaped for Their Target? , 2011, Molecular informatics.
[41] Aurélien Grosdidier,et al. SwissDock, a protein-small molecule docking web service based on EADock DSS , 2011, Nucleic Acids Res..
[42] Xiaofeng Liu,et al. SHAFTS: A Hybrid Approach for 3D Molecular Similarity Calculation. 1. Method and Assessment of Virtual Screening , 2011, J. Chem. Inf. Model..
[43] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[44] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[45] G. Schneider,et al. Scaffold‐Hopping Potential of Ligand‐Based Similarity Concepts , 2006, ChemMedChem.